ENDONOVO THERAPEUTICS, INC. Quarterly Cost of Revenue in USD from Q2 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Endonovo Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2018 to Q3 2023.
  • Endonovo Therapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $827.000, a 79.5% decline year-over-year.
  • Endonovo Therapeutics, Inc. annual Cost of Revenue for 2022 was $9.99K, a 33.3% decline from 2021.
  • Endonovo Therapeutics, Inc. annual Cost of Revenue for 2021 was $15K, a 77.1% decline from 2020.
  • Endonovo Therapeutics, Inc. annual Cost of Revenue for 2020 was $65.4K, a 30% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $827 -$3.2K -79.5% Jul 1, 2023 Sep 30, 2023 10-Q/A 2023-12-29
Q1 2023 $13.3K $4K +$3.28K +460% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $9.99K $4.87K -$4K -45.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 $14K $4.03K +$924 +29.8% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-12-29
Q2 2022 $13.1K $383 -$117 -23.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $13.2K $714 -$1.81K -71.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $15K $8.86K -$38.2K -81.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $53.2K $3.1K +$2.34K +308% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $50.8K $500 -$10.8K -95.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 $61.6K $2.52K -$3.74K -59.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-19
Q4 2020 $65.4K $47K -$127 -0.27% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-14
Q3 2020 $65.5K $760 -$8.17K -91.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 $73.7K $11.3K -$18.3K -61.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $91.9K $6.26K -$1.45K -18.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 $93.4K $47.2K Oct 1, 2019 Dec 31, 2019 10-K 2021-04-13
Q3 2019 $8.93K +$4.61K +107% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-19
Q2 2019 $29.6K +$29K +5277% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 $7.71K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-12
Q3 2018 $4.31K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $550 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.